ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(−2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients

Cyclophosphamide 1.5 g m(−2)followed by granulocyte colony-stimulating factor (G-CSF) is an effective peripheral blood stem cell (PBSC) mobilizing regimen, but has limited anti-lymphoma activity. We therefore assessed the mobilizing potential of ESHAP (etoposide, ara-C, methylprednisolone and cispla...

Descripción completa

Detalles Bibliográficos
Autores principales: Watts, M J, Ings, S J, Leverett, D, MacMillan, A, Devereux, S, Goldstone, A H, Linch, D C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363271/
https://www.ncbi.nlm.nih.gov/pubmed/10646877
http://dx.doi.org/10.1054/bjoc.1999.0915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363271/
https://www.ncbi.nlm.nih.gov/pubmed/10646877
http://dx.doi.org/10.1054/bjoc.1999.0915

Ejemplares similares